{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:59:56Z","timestamp":1774533596218,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570701"],"award-info":[{"award-number":["81570701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770849"],"award-info":[{"award-number":["81770849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922074"],"award-info":[{"award-number":["81922074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","award":["2016KZDXM041"],"award-info":[{"award-number":["2016KZDXM041"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.biopha.2021.111685","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T18:12:44Z","timestamp":1620324764000},"page":"111685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies"],"prefix":"10.1016","volume":"140","author":[{"given":"Shuang","family":"Hua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danqi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jufei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaixuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglu","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dewei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.biopha.2021.111685_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020","volume":"69","author":"Garg","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"10229","key":"10.1016\/j.biopha.2021.111685_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"10223","key":"10.1016\/j.biopha.2021.111685_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41574-020-0353-9","article-title":"Endocrine and metabolic link to coronavirus infection","volume":"16","author":"Bornstein","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111685_bib5","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically Ill patients with coronavirus disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2021.111685_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"43","key":"10.1016\/j.biopha.2021.111685_bib7","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111685_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00240-010-0255-8","article-title":"Antiapoptotic effect of angiotensin-II type-1 receptor blockade in renal tubular cells of hyperoxaluric rats","volume":"38","author":"Tun\u00e7demir","year":"2010","journal-title":"Urol. Res."},{"key":"10.1016\/j.biopha.2021.111685_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.biopha.2021.111685_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1753944708098691","article-title":"Olmesartan improves left ventricular function in pressure-overload hypertrophied rat heart by blocking angiotensin II receptor with synergic effects of upregulation of angiotensin converting enzyme 2","volume":"3","author":"Kaiqiang","year":"2009","journal-title":"Ther. Adv. Cardiovasc Dis."},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2020.11.014","article-title":"Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes","volume":"33","author":"Yu","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2021.111685_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/220819a0","article-title":"Relation between blood groups and resistance to infection with influenza and some picornaviruses","volume":"220","author":"Tyrrell","year":"1968","journal-title":"Nature"},{"issue":"7440","key":"10.1016\/j.biopha.2021.111685_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/495176a","article-title":"Public health: broad reception for coronavirus","volume":"495","author":"Gallagher","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111685_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2021.111685_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111685_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1753944715597623","article-title":"ACE2 and vasoactive peptides: novel players in cardiovascular\/renal remodeling and hypertension","volume":"9","author":"Mendoza-Torres","year":"2015","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jcp.29889","article-title":"The emerging role of angiotensinogen in cardiovascular diseases","volume":"236","author":"Xu","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111685_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/ajh\/hpz146","article-title":"Angiotensin-(1-7): translational avenues in cardiovascular control","volume":"32","author":"Medina","year":"2019","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biopha.2021.111685_bib21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41401-020-0430-6","article-title":"Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication","volume":"41","author":"Pang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.biopha.2021.111685_bib22","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111685_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108175","article-title":"A single-cell RNA expression map of human coronavirus entry factors","volume":"32","author":"Singh","year":"2020","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.biopha.2021.111685_bib24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111685_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-019-0165-y","article-title":"Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus","volume":"15","author":"Guilherme","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111685_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrg3941","article-title":"Exploring the emerging complexity in transcriptional regulation of energy homeostasis","volume":"16","author":"Lempradl","year":"2015","journal-title":"Nat. Rev. Genet"},{"issue":"5","key":"10.1016\/j.biopha.2021.111685_bib27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10238","key":"10.1016\/j.biopha.2021.111685_bib28","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111685_bib29","doi-asserted-by":"crossref","unstructured":"Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A., Zhou J., Shi G., Fang N., Fan J. et al.: Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. bioRxiv 2020:2020.2002.2003.931766.","DOI":"10.1101\/2020.02.03.931766"},{"key":"10.1016\/j.biopha.2021.111685_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","article-title":"Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19","volume":"32","author":"Kusmartseva","year":"2020","journal-title":"Cell Metab."},{"issue":"19","key":"10.1016\/j.biopha.2021.111685_bib32","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","article-title":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin\u2013angiotensin\u2013aldosterone inhibitors","volume":"41","author":"Sama","year":"2020","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2020.03.055","article-title":"Pancreatic injury patterns in patients with coronavirus Disease 19 pneumonia","volume":"159","author":"Wang","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.biopha.2021.111685_bib34","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.2337\/db10-1205","article-title":"ACE2 and diabetes: ACE of ACEs?","volume":"59","author":"Batlle","year":"2010","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2021.111685_bib35","doi-asserted-by":"crossref","first-page":"35876","DOI":"10.1371\/journal.pone.0035876","article-title":"Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts","volume":"7","author":"Bertram","year":"2012","journal-title":"PLoS One"},{"issue":"10223","key":"10.1016\/j.biopha.2021.111685_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biopha.2021.111685_bib37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111685_bib38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000452269","article-title":"Protease-activated receptor 1 contributes to angiotensin II-induced cardiovascular remodeling and inflammation","volume":"136","author":"Antoniak","year":"2017","journal-title":"Cardiology"},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib39","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/gutjnl-2020-320832","article-title":"Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus","volume":"69","author":"Liang","year":"2020","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.biopha.2021.111685_bib40","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.biopha.2021.111685_bib41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib42","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/gutjnl-2020-321051","article-title":"COVID-19 in gastroenterology: a clinical perspective","volume":"69","author":"Ong","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.biopha.2021.111685_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150861","article-title":"Anti-inflammatory action of angiotensin 1-7 in experimental colitis","volume":"11","author":"Khajah","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111685_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: the role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib45","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2021.111685_bib46","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM Consortium Position Paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111685_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/BS9.0000000000000050","article-title":"T cell response in patients with COVID-19","volume":"2","author":"Liu","year":"2020","journal-title":"Blood Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"Wang","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jcb.26174","article-title":"Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of Type 2 diabetes mellitus","volume":"119","author":"Akash","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2021.111685_bib50","doi-asserted-by":"crossref","first-page":"F1005","DOI":"10.1152\/ajprenal.00535.2016","article-title":"Tumor necrosis factor-\u03b1, kidney function, and hypertension","volume":"313","author":"Mehaffey","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111685_bib51","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","article-title":"Targeting innate immune mediators in type 1 and type 2 diabetes","volume":"19","author":"Donath","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111685_bib52","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1210\/er.2019-00002","article-title":"Inflammation in the pathophysiology and therapy of cardiometabolic disease","volume":"40","author":"Donath","year":"2019","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00592-013-0543-1","article-title":"The inflammatory status score including IL-6, TNF-\u03b1, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus","volume":"51","author":"Daniele","year":"2014","journal-title":"Acta Diabetol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111685_bib54","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.dsx.2019.04.046","article-title":"Association of glycemic status and interferon-gamma production with leukocytes and platelet indices alterations in type2 diabetes","volume":"13","author":"Abdel-Moneim","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.biopha.2021.111685_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7457269","article-title":"Role of adaptive and innate immunity in Type 2 diabetes mellitus","volume":"2018","author":"Zhou","year":"2018","journal-title":"J. Diabetes Res."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.111685_bib56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","article-title":"T cell-mediated immune response to respiratory coronaviruses","volume":"59","author":"Channappanavar","year":"2014","journal-title":"Immunol. Res"},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib57","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cmet.2013.05.011","article-title":"Innate immune receptors: key regulators of metabolic disease progression","volume":"17","author":"Jin","year":"2013","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.biopha.2021.111685_bib58","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cmet.2020.07.015","article-title":"Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis","volume":"32","author":"Codo","year":"2020","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.biopha.2021.111685_bib59","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/dbi20-0022","article-title":"Managing hyperglycemia in the COVID-19 inflammatory storm","volume":"69","author":"Gianchandani","year":"2020","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.biopha.2021.111685_bib60","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/ijms19102863","article-title":"Metformin: an old drug with new applications","volume":"19","author":"Zhou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib61","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S2666-7568(20)30033-7","article-title":"Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis","volume":"2","author":"Bramante","year":"2021","journal-title":"Lancet Healthy Longev."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","article-title":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis","volume":"103","author":"Luo","year":"2020","journal-title":"Am. J. Trop. Med Hyg."},{"issue":"7","key":"10.1016\/j.biopha.2021.111685_bib63","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/dc20-0660","article-title":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.biopha.2021.111685_bib64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201712-2570OC","article-title":"AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension","volume":"198","author":"Zhang","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.111685_bib65","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.dsx.2020.07.003","article-title":"Hypoglycemia at the time of Covid-19 pandemic","volume":"14","author":"Shah","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib66","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cmet.2020.11.015","article-title":"Glucose or insulin, which is the culprit in patients with COVID-19 and diabetes?","volume":"33","author":"Donath","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2021.111685_bib68","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist","volume":"225","author":"Asperen","year":"2011","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111685_bib69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/gb-2003-4-8-225","article-title":"Angiotensin-I-converting enzyme and its relatives","volume":"4","author":"Riordan","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2021.111685_bib70","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142032","article-title":"Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease","volume":"5","author":"Golden","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2021.111685_bib71","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biopha.2021.111685_bib72","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1113\/expphysiol.2007.041855","article-title":"Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and ditary sodium restriction in healthy rats","volume":"93","author":"Hamming","year":"2008","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.biopha.2021.111685_bib73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.wem.2011.09.002","article-title":"Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia","volume":"23","author":"Kleinsasser","year":"2012","journal-title":"Wilderness Environ. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit. Care"},{"issue":"7047","key":"10.1016\/j.biopha.2021.111685_bib75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.111685_bib76","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1136\/bmj.e4260","article-title":"Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis","volume":"345","author":"Caldeira","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib77","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"12","key":"10.1016\/j.biopha.2021.111685_bib78","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29058","article-title":"Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19","volume":"3","author":"Rosenthal","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.biopha.2021.111685_bib79","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res"},{"issue":"7","key":"10.1016\/j.biopha.2021.111685_bib80","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamacardio.2020.1282","article-title":"Coronavirus disease 2019 (COVID-19) infection and renin angiotensin system blockers","volume":"5","author":"Bavishi","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111685_bib81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib82","first-page":"4","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","volume":"7","author":"Jin","year":"2020","journal-title":"Mil. Med. Res."},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib83","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.biopha.2021.111685_bib84","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","article-title":"Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility","volume":"100","author":"Ji","year":"2020","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2021.111685_bib85","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcyt.2020.04.100","article-title":"Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies","volume":"22","author":"Cancio","year":"2020","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.biopha.2021.111685_bib86","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/ATVBAHA.120.315229","article-title":"ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart","volume":"41","author":"Sakamoto","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.biopha.2021.111685_bib87","doi-asserted-by":"crossref","first-page":"117905","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.biopha.2021.111685_bib88","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"issue":"9","key":"10.1016\/j.biopha.2021.111685_bib89","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","article-title":"ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection","volume":"18","author":"Liu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221004674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221004674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:04:25Z","timestamp":1774530265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221004674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":89,"alternative-id":["S0753332221004674"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111685","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111685"}}